Pesquisas alternativas:
forced phase » force phase (Expandir a Pesquisa), sourced phase (Expandir a Pesquisa), forced pace (Expandir a Pesquisa)
formed phase » informed phase (Expandir a Pesquisa), armed phase (Expandir a Pesquisa), forms phase (Expandir a Pesquisa)
forced phase » force phase (Expandir a Pesquisa), sourced phase (Expandir a Pesquisa), forced pace (Expandir a Pesquisa)
formed phase » informed phase (Expandir a Pesquisa), armed phase (Expandir a Pesquisa), forms phase (Expandir a Pesquisa)
1
Por European Food Safety Authority (EFSA), Andrea Carvelli, Søren Saxmose Nielsen, Romain Paillot, Alessandro Broglia, Lisa Kohnle
Publicado em 2022-04-01
“... and possibly fatal neurological forms. From the epidemiological and genomic viewpoint, there are no specific...”Publicado em 2022-04-01
Obter o texto integral
Artigo
2
Por ESKANDARI, Seyed Ebrahim, FIROOZ, Alireza, NASSIRI-KASHANI, Mansour, JAAFARI, Mahmoud Reza, JAVADI, Amir, MIRAMIN MOHAMMADI, Akram, KHAMESIPOUR, Ali
Publicado no Iran J Parasitol (2019)
“...BACKGROUND: We aimed to evaluate the safety of SinaAmpholeish in a double-blind, randomized, phase...”Publicado no Iran J Parasitol (2019)
Obter o texto integral
Obter o texto integral
Artigo
3
Por Lubaroff, David M., Konety, Badrinath R., Link, Brian, Gerstbrein, Jack, Madsen, Tammy, Shannon, Mary, Howard, Jeanne, Paisley, Jennifer, Boeglin, Diana, Ratliff, Timothy L., Williams, Richard D.
Publicado em 2009
“...PURPOSE: We performed a phase I clinical trial of adenovirus/PSA (Ad/PSA) vaccine in men...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“...Gout is a common form of arthritis; however, there are currently no effective therapies available...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Gotfried, Mark H., Girod, Carlos E., Antin-Ozerkis, Danielle, Burgess, Tracy, Strombom, Indiana, Stauffer, John L., Kirchgaessler, Klaus-Uwe, Padilla, Maria L.
Publicado no Pulm Ther (2018)
“...INTRODUCTION: PIPF-002 was a phase 2, multicenter, open-label study of pirfenidone in patients...”Publicado no Pulm Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Miller, Robert G., Block, Gilbert, Katz, Jonathan S., Barohn, Richard J., Gopalakrishnan, Vidhya, Cudkowicz, Merit, Zhang, Jane R., McGrath, Michael S., Ludington, Elizabeth, Appel, Stan H., Azhir, Ari
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)
“...OBJECTIVE: To assess the safety, tolerability, and preliminary efficacy of NP001, a novel immune...”Publicado no Neurol Neuroimmunol Neuroinflamm (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Tao Wang, Weihong Kuang, Wei Chen, Wenwei Xu, Liming Zhang, Yingjie Li, Hailin Li, Ying Peng, Yangmei Chen, Baojun Wang, Jinsong Xiao, Honghua Li, Chuanzhu Yan, Yifeng Du, Mouni Tang, Zhiyi He, Haibo Chen, Wei Li, Hong Lin, Shugui Shi, Jianzhong Bi, Huadong Zhou, Yan Cheng, Xiaoping Gao, Yihui Guan, Qiu Huang, Kewei Chen, Xianliang Xin, Jian Ding, Meiyu Geng, Shifu Xiao
Publicado em 2020-09-01
Assuntos:
“...Safety...”Publicado em 2020-09-01
Obter o texto integral
Artigo
8
Por Sarwar, Uzma N., Costner, Pamela, Enama, Mary E., Berkowitz, Nina, Hu, Zonghui, Hendel, Cynthia S., Sitar, Sandra, Plummer, Sarah, Mulangu, Sabue, Bailer, Robert T., Koup, Richard A., Mascola, John R., Nabel, Gary J., Sullivan, Nancy J., Graham, Barney S., Ledgerwood, Julie E.
Publicado no J Infect Dis (2015)
“... by Biojector) at weeks 0, 4, and 8, with a homologous boost at or after week 32. Safety evaluations included...”Publicado no J Infect Dis (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Winthrop, Kevin L., Wouters, Ann G., Choy, Ernest H., Soma, Koshika, Hodge, Jennifer A., Nduaka, Chudy I., Biswas, Pinaki, Needle, Elie, Passador, Sherry, Mojcik, Christopher F., Rigby, William F.
Publicado no Arthritis Rheumatol (2017)
“... effect on the immune response and safety of live zoster vaccine (LZV). METHODS: In this phase II, 14‐week...”Publicado no Arthritis Rheumatol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Marty, Francisco M., Man, Choy Y., van der Horst, Charles, Francois, Bruno, Garot, Denis, Máňez, Rafael, Thamlikitkul, Visanu, Lorente, José A., Álvarez-Lerma, Francisco, Brealey, David, Zhao, Henry H., Weller, Steve, Yates, Phillip J., Peppercorn, Amanda F.
Publicado em 2014
“... in viral load of 1.42 log(10) copies/mL after 2 days of treatment. Conclusions. Safety, pharmacokinetic...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Bekker, L.G., Li, S., Pathak, S., Tolley, E.E., Marzinke, M.A., Justman, J.E., Mgodi, N.M., Chirenje, M., Swaminathan, S., Adeyeye, A., Farrior, J., Hendrix, C.W., Piwowar-Manning, E., Richardson, P., Eshelman, S.H., Redinger, H., Williams, P., Sista, N.D.
Publicado no EClinicalMedicine (2020)
“... 02165202) was a phase 2, double-blind, 2:1 randomized trial comparing the safety of 1200mg RPV LA (LA...”Publicado no EClinicalMedicine (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Kipnes, Mark S., Handley, Alison, Lloyd, Eric, Barger, Bruce, Roberts, Andrew
Publicado no J Clin Hypertens (Greenwich) (2015)
“...A phase 3, 26‐week, open‐label, titrate‐to‐target study (n=418) assessed the safety of azilsartan...”Publicado no J Clin Hypertens (Greenwich) (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... after the infusion of 100 mL saline. The serological markers tests were used to assess safety and the 28...”
Obter o texto integral
Obter o texto integral
Artigo
14
Por Fritz, Sara E., Henson, Michael S., Greengard, Emily, Winter, Amber L., Stuebner, Kathleen M., Yoon, Una, Wilk, Vicki L., Borgatti, Antonella, Augustin, Lance B., Modiano, Jaime F., Saltzman, Daniel A.
Publicado no Vet Med Sci (2016)
“...We conducted a prospective phase I study to evaluate safety of an orally administered Salmonella...”Publicado no Vet Med Sci (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, Arlene Hurley, Angela Lombardo, Soe Than, Phumla Adesanya, Catherine Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed, Lorna Clark, Daniel Dugin, Mar Boente-Carrera, Claudia Schmidt, Qing Fang, LeiBa, Yaoxing Huang, Gerasimos J Zaharatos, David F Gardiner, Marina Caskey, Laura Seamons, Martin Ho, Len Dally, Carol Smith, Josephine Cox, Dilbinder Gill, Jill Gilmour, Michael C Keefer, Patricia Fast, David D Ho
Publicado em 2010-01-01
“...We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine...”Publicado em 2010-01-01
Obter o texto integral
Artigo
16
Por Vasan, Sandhya, Schlesinger, Sarah J., Chen, Zhiwei, Hurley, Arlene, Lombardo, Angela, Than, Soe, Adesanya, Phumla, Bunce, Catherine, Boaz, Mark, Boyle, Rosanne, Sayeed, Eddy, Clark, Lorna, Dugin, Daniel, Boente-Carrera, Mar, Schmidt, Claudia, Fang, Qing, Lei, Huang, Yaoxing, Zaharatos, Gerasimos J., Gardiner, David F., Caskey, Marina, Seamons, Laura, Ho, Martin, Dally, Len, Smith, Carol, Cox, Josephine, Gill, Dilbinder, Gilmour, Jill, Keefer, Michael C., Fast, Patricia, Ho, David D.
Publicado em 2010
“...BACKGROUND: We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Beier, Jutta, Fuhr, Rainard, Seoane, Beatriz, Massana, Eric, de Miquel, Gonzalo, Pujol, Helena, Ruiz, Sandrine
Publicado no Pharmacol Res Perspect (2017)
“... of asthma and chronic obstructive pulmonary disease. We assessed the efficacy, safety, and tolerability...”Publicado no Pharmacol Res Perspect (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Gaudinski, Martin R, Houser, Katherine V, Morabito, Kaitlyn M, Hu, Zonghui, Yamshchikov, Galina, Rothwell, Ro Shauna, Berkowitz, Nina, Mendoza, Floreliz, Saunders, Jamie G, Novik, Laura, Hendel, Cynthia S, Holman, LaSonji A, Gordon, Ingelise J, Cox, Josephine H, Edupuganti, Srilatha, McArthur, Monica A, Rouphael, Nadine G, Lyke, Kirsten E, Cummings, Ginny E, Sitar, Sandra, Bailer, Robert T, Foreman, Bryant M, Burgomaster, Katherine, Pelc, Rebecca S, Gordon, David N, DeMaso, Christina R, Dowd, Kimberly A, Laurencot, Carolyn, Schwartz, Richard M, Mascola, John R, Graham, Barney S, Pierson, Theodore C, Ledgerwood, Julie E, Chen, Grace L
Publicado no Lancet (2018)
“... in VRC 319 and two in VRC 320 withdrew after one dose of vaccine, but were included in the safety...”Publicado no Lancet (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Ishiguro, Megumi, Mochizuki, Hidetaka, Tomita, Naohiro, Shimada, Yasuhiro, Takahashi, Keiichi, Kotake, Kenjiro, Watanabe, Masahiko, Kanemitsu, Yukihide, Ueno, Hideki, Ishikawa, Toshiaki, Uetake, Hiroyuki, Matsui, Shigeyuki, Teramukai, Satoshi, Sugihara, Kenichi
Publicado em 2012
“.... METHODS/DESIGN: SACURA trial is a multicenter randomized phase III study which aims to evaluate...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por De Vivo, Darryl C., Bertini, Enrico, Swoboda, Kathryn J., Hwu, Wuh-Liang, Crawford, Thomas O., Finkel, Richard S., Kirschner, Janbernd, Kuntz, Nancy L., Parsons, Julie A., Ryan, Monique M., Butterfield, Russell J., Topaloglu, Haluk, Ben-Omran, Tawfeg, Sansone, Valeria A., Jong, Yuh-Jyh, Shu, Francy, Staropoli, John F., Kerr, Douglas, Sandrock, Alfred W., Stebbins, Christopher, Petrillo, Marco, Braley, Gabriel, Johnson, Kristina, Foster, Richard, Gheuens, Sarah, Bhan, Ishir, Reyna, Sandra P., Fradette, Stephanie, Farwell, Wildon
Publicado no Neuromuscul Disord (2019)
“... and weakness in the limbs and trunk. We report interim efficacy and safety outcomes as of March 29, 2019 in 25...”Publicado no Neuromuscul Disord (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo